Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01HL086917-02
The Role of Nitric Oxide Synthase in Circulating Progenitor Cell Function
National Institutes of Health
Grant: 4UM1HL087318-10
Data Coordinating Center For The Cardiovascular Cell Therapy Research Network
National Institutes of Health
Grant: 1R21HL097129-01A2
Bone marrow cell therapy for cardiac disease: Impact of donor age and infarction
FWCI
0.34
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals